期刊文献+

CpG ODN佐剂对乙肝疫苗抗原免疫原性的影响 被引量:4

The effect of CpG oligodeoxynucleotide adjuvant on immunogenicity of hepatitis B vaccine antigen
下载PDF
导出
摘要 目的探究CpG ODN佐剂对不同抗原含量乙肝疫苗免疫效果的影响。方法在体液免疫方面不同抗原浓度的CpG ODN与Al(OH)3佐剂乙肝疫苗免疫Balb/c小鼠,于免疫后第2、4、6、8、10周收集血清,检测小鼠体内相对效力ED50和血清中的anti-HBs抗体水平;在细胞免疫方面测定诱导产生IFN-γ水平及IgG2a应答水平。结果 CpG ODN与Al(OH)3佐剂可以有效协同HBs Ag诱导机体产生的抗体滴度达49 427 mIU/ml,抗体效价随时间延长而增加。乙肝抗原减半后双佐剂乙肝疫苗诱导机体产生的特异性抗体滴度可达41 225 mIU/ml,高于无CpG ODN佐剂的铝佐剂疫苗。在诱导细胞分泌方面,对照组诱导产生IFN-γ水平及IgG2a应答水平明显低于所有双佐剂疫苗组。结论 CpG ODN对HBsAg具有良好佐剂活性,并与铝佐剂有协同作用,二者联合应用可以降低乙肝抗原用量并提高疫苗免疫原性。 To investigate the impact of CpG ODN adjuvant on immunogenicity of hepatitis B vaccine,Balb/c mice were vaccinated by CpG ODN in combination with Al(OH)3as adjuvants together with different antigen amount.After 2,4,6,8 and 10 weeks,serum was collected from the mice and the levels of serum hepatitis surface antibody(anti-HBs) and ED50 were detected.Data showed that high level of antibody was effectively induced by CpG ODN in combination with Al(OH)3as adjuvants;and antibody level was increased over time and the highest titer reached49 427 mIU/ml.When the amount of hepatitis B antigen was halved,the CpG ODN+Al(OH)3adjuvanted vaccine still induced higher antibody titer(41 225 mIU/ml),as compared with hepatitis B vaccine with Al(OH)3adjuvant only.Furthermore,all double adjuvant vaccine groups induced obvious higher IFN-γ level than that of control group.Taken together,CpG ODN has good adjuvanticity and works synergistically with Al(OH)3as well,thus can improves immunogenicity of HBsAg and reduces antigen amount in half.
出处 《免疫学杂志》 CAS CSCD 北大核心 2014年第10期878-881,共4页 Immunological Journal
基金 国家高技术研究发展计划(2012AA02A404)
关键词 CPG ODN 乙型肝炎疫苗 免疫原性 CpG ODN Hepatitis B vaccine Immunogenicity
  • 相关文献

参考文献10

  • 1Cooper C, Mackie D. Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAVTM safety and efficacy[J]. Expert Rev Vaccines, 2011, 10(4): 417-427.
  • 2Asanuma H, Zamri NB, Sekine S, et al. A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging[J]. Vaccine, 2012, 30(4): 803-812.
  • 3赵俊杰,付承英.CpG ODN生物学活性和免疫作用的研究进展[J].现代免疫学,2011,31(2):168-171. 被引量:6
  • 4Sugai T, Mori M, Nakazawa M, et al. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Thl/Th2 immune response in diphtheria-tetanus-pertussis vaccine [J]. Vaccine, 2005, 23(46): 5450-5456.
  • 5Krieg AM. Therapeutic potential of Toll-like receptor 9 activation[J]. Nat Rev Drug Discov, 2006, 5(6): 471-484.
  • 6Hopkins R J, Daczkowski NF, Kaptur PE, et al. Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of anthrax vaccine adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers[J]. Vaccine, 2013, 31(30): 3051-3058.
  • 7Vincent IE, Lucifora J, Durantel D, et al. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro[J]. Antivir Ther, 2009, 14(1): 131-135.
  • 8冯晓异,杨喆,刘红岩,徐娅妮,陈明,阳选祥,卢松,浦勇,张益丽.CpG ODN联合乙型肝炎疫苗与乙型肝炎疫苗免疫效果对比研究[J].免疫学杂志,2011,27(3):232-233. 被引量:7
  • 9何鹏,张现臣,胡忠玉,方鑫,邱少辉,梁争论.新型CpG佐剂——BW006协同乙型肝炎病毒表面抗原活化小鼠B、T淋巴细胞的作用[J].医学研究杂志,2011,40(11):27-32. 被引量:1
  • 10Wang S, Han Q, Zhang N, et al. HBcAgl8-27 epitope fused to HIV-Tat49-57 adjuvauted with CpG ODN induces immunotherapeutic effects in transgenic mice [J]. Immunol Lett, 2010, 127(2): 143-149.

二级参考文献42

共引文献11

同被引文献52

  • 1向晓星,周霞秋,王俊学,谢青,蔡雄,俞红,周惠娟.CpG-ODN联合HBsAg体外对慢性乙肝患者外周血树突状细胞STAT、SOCS通路的影响[J].中华微生物学和免疫学杂志,2005,25(11):919-922. 被引量:2
  • 2陈军浩,吴超,欧阳建,刘勇,耿东进.CpG寡核苷酸对人外周血B淋巴细胞免疫刺激作用[J].现代检验医学杂志,2006,21(4):1-3. 被引量:5
  • 3曾瑞红,梅兴国,龚伟,亓晓温.RSV CTL表位与G蛋白片段的融合表达对G蛋白片段诱导的免疫应答的调节作用[J].中国免疫学杂志,2007,23(5):387-390. 被引量:9
  • 4O'Hagan DT. Vaccine Adjuvants[M]. New Jersey: Humana Press Totowa, 2000: 1-49.
  • 5Hansen B, Sokolovska A, HogenEsch H, et al. Relationship between the strength of antigen adsorption to an aluminum- containing adjuvant and the immune response[J]. Vaccine, 2007, 25(36): 6618-6624.
  • 6Ljutic B, Ochs M, Messtham B, et al. Formulation, stability and immunogenieity of a trivalent pneumocoeeal protein vaccine formulated with aluminum salt adjuvants [J]. Vaccine, 2012, 30(19): 2981-2988.
  • 7Jiang DP, Morefield GL, HogenEseh H, et al. Relationship of adsorption mechanism of antigens by aluminum- containing adjuvants to in vitro elution in interstitial fluid[J]. Vaccine, 2006, 24(10): 1665-1669.
  • 8HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants[J]. Vaccine, 2002, 20(Suppl 3): $34-$39.
  • 9Hogen Esch H. Mechanism of immunopoteintiation and safty of aluminum adjuvant[J]. Frontiers Immunol, 2013, 3: 1-13.
  • 10Lu FJ, Boutselis I, Borch RF, et al. Control of antigen- binding to aluminum adjuvants and the immune response with a novel phosphonate linker[J]. Vaccine, 2013, 31(42): 4362- 4367.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部